Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) SEC filings
GLMD SEC filings moved a median of -1.10% by the close. GLMD SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GLMD overview →
95 measured GLMD SEC filing events.
Where these GLMD SEC filings landedvs 94 measured GLMD SEC filing reactions
| Middle 50% of GLMD SEC filing reactions | -4.20% to +2.48% |
|---|---|
| Median reaction (to close) | -1.10% |
| Measured reactions | 94 |
Point-in-time · zero look-ahead
Half of the 94 GLMD SEC filing events with a measured close landed between -4.20% and +2.48%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K Galmed Pharmaceuticals For: Sep 09 | SEC filing · Form 6-K | -2.30% | +18.41% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 08 | SEC filing · Form 6-K | +0.00% | +0.39% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | — | -0.77% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 03 | SEC filing · Form 6-K | — | -0.77% | |
| Form 6-K Galmed Pharmaceuticals For: Jun 30 | SEC filing · Form 6-K | -3.70% | -3.21% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 02 | SEC filing · Form 6-K | -3.70% | -3.21% | |
| Form POS AM Galmed Pharmaceuticals | SEC filing · Form POS | -3.70% | -3.21% | |
| Form 6-K Galmed Pharmaceuticals For: Aug 19 | SEC filing · Form 6-K | -3.35% | -11.34% | |
| Form 6-K/A Galmed Pharmaceuticals For: Jul 22 | SEC filing · Form 6-K | -1.75% | +0.00% | |
| Form 6-K Galmed Pharmaceuticals For: Aug 17 | SEC filing · Form 6-K | +4.85% | -1.27% | |
| Form 6-K Galmed Pharmaceuticals For: Aug 14 | SEC filing · Form 6-K | +4.85% | -1.27% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 31 | SEC filing · Form 6-K | -2.97% | -4.60% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 29 | SEC filing · Form 6-K | +0.00% | +10.74% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 28 | SEC filing · Form 6-K | -6.99% | +0.94% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 22 | SEC filing · Form 6-K | — | +12.88% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 16 | SEC filing · Form 6-K | -6.12% | +0.86% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 08 | SEC filing · Form 6-K | -0.09% | +2.06% | |
| Form 6-K Galmed Pharmaceuticals For: Jun 22 | SEC filing · Form 6-K | -0.84% | +2.56% | |
| Form 6-K Galmed Pharmaceuticals For: Jun 08 | SEC filing · Form 6-K | -3.88% | -20.87% | |
| Form POS EX Galmed Pharmaceuticals | SEC filing · Form POS | -3.88% | -20.87% | |
| Form 6-K Galmed Pharmaceuticals For: Jun 02 | SEC filing · Form 6-K | +2.01% | -6.01% | |
| Form 6-K Galmed Pharmaceuticals For: May 14 | SEC filing · Form 6-K | -1.71% | +13.53% | |
| Form 6-K Galmed Pharmaceuticals For: May 06 | SEC filing · Form 6-K | — | +6.41% | |
| Form 6-K Galmed Pharmaceuticals For: Apr 14 | SEC filing · Form 6-K | -5.03% | -12.04% | |
| Form 6-K Galmed Pharmaceuticals For: Apr 09 | SEC filing · Form 6-K | -10.96% | -31.12% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | +0.00% | +1.89% | |
| Form 20-F Galmed Pharmaceuticals For: Dec 31 | SEC filing · Form 20-F | +0.00% | +0.97% | |
| Form POS AM Galmed Pharmaceuticals | SEC filing · Form POS | +0.00% | +0.97% | |
| Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 | Press release | +0.00% | +0.97% | |
| Form 6-K Galmed Pharmaceuticals For: Mar 05 | SEC filing · Form 6-K | -0.79% | +3.94% | |
| Form 6-K Galmed Pharmaceuticals For: Mar 04 | SEC filing · Form 6-K | — | +8.25% | |
| Form 6-K Galmed Pharmaceuticals For: Feb 09 | SEC filing · Form 6-K | -0.53% | -3.32% | |
| Form 6-K Galmed Pharmaceuticals For: Jan 30 | SEC filing · Form 6-K | +0.00% | -5.79% | |
| Form 6-K Galmed Pharmaceuticals For: Dec 08 | SEC filing · Form 6-K | +0.89% | +8.04% | |
| Form 6-K Galmed Pharmaceuticals For: Dec 04 | SEC filing · Form 6-K | -1.35% | +1.80% | |
| Form 6-K Galmed Pharmaceuticals For: Dec 01 | SEC filing · Form 6-K | -0.34% | +2.21% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 30 | SEC filing · Form 6-K | +3.64% | +14.05% | |
| Form 6-K Galmed Pharmaceuticals For: Nov 18 | SEC filing · Form 6-K | +2.25% | -1.80% | |
| Form 6-K Galmed Pharmaceuticals For: Nov 17 | SEC filing · Form 6-K | -1.60% | -16.00% | |
| Form 6-K Galmed Pharmaceuticals For: Oct 29 | SEC filing · Form 6-K | -0.75% | +0.00% | |
| Form 6-K Galmed Pharmaceuticals For: Oct 28 | SEC filing · Form 6-K | +0.00% | -8.16% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 19 | SEC filing · Form 6-K | +0.00% | -1.34% | |
| Form S-8 Galmed Pharmaceuticals | SEC filing · Form S-8 | +0.00% | -1.34% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | +0.00% | +4.03% | |
| Form 6-K Galmed Pharmaceuticals For: Jun 30 | SEC filing · Form 6-K | +0.00% | -2.13% | |
| Form POS AM Galmed Pharmaceuticals | SEC filing · Form POS | +0.75% | -5.22% | |
| Form 6-K Galmed Pharmaceuticals For: Aug 25 | SEC filing · Form 6-K | -4.91% | -13.50% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | -1.83% | +2.76% | |
| Form F-1 Galmed Pharmaceuticals | SEC filing · Form F-1 | -4.11% | — | |
| Form 6-K Galmed Pharmaceuticals For: Aug 15 | SEC filing · Form 6-K | +2.12% | +6.16% | |
| Form 6-K Galmed Pharmaceuticals For: Aug 14 | SEC filing · Form 6-K | -0.69% | -1.37% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 24 | SEC filing · Form 6-K | -3.60% | +2.05% | |
| Form 6-K Galmed Pharmaceuticals For: May 27 | SEC filing · Form 6-K | +0.00% | +4.96% | |
| Form 6-K Galmed Pharmaceuticals For: May 22 | SEC filing · Form 6-K | -1.45% | +2.17% | |
| Form 6-K Galmed Pharmaceuticals For: May 13 | SEC filing · Form 6-K | +0.79% | +1.57% | |
| Form 6-K Galmed Pharmaceuticals For: May 06 | SEC filing · Form 6-K | -2.33% | -2.67% | |
| Form 6-K Galmed Pharmaceuticals For: Apr 28 | SEC filing · Form 6-K | -1.80% | -33.20% | |
| Form 6-K Galmed Pharmaceuticals For: Apr 17 | SEC filing · Form 6-K | +9.00% | +4.54% | |
| Form 6-K Galmed Pharmaceuticals For: Apr 15 | SEC filing · Form 6-K | -3.03% | +6.82% | |
| Form 6-K Galmed Pharmaceuticals For: Apr 10 | SEC filing · Form 6-K | +2.27% | -4.54% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | +0.77% | +9.23% | |
| Form 20-F Galmed Pharmaceuticals For: Dec 31 | SEC filing · Form 20-F | -1.33% | -2.67% | |
| Form POS AM Galmed Pharmaceuticals | SEC filing · Form POS | -1.33% | -2.67% | |
| Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024 | Press release | -1.33% | -2.67% | |
| Form 6-K Galmed Pharmaceuticals For: Mar 20 | SEC filing · Form 6-K | -9.56% | -1.31% | |
| Form S-8 Galmed Pharmaceuticals | SEC filing · Form S-8 | -3.32% | -2.33% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | +0.00% | -2.13% | |
| Form 6-K Galmed Pharmaceuticals For: Nov 14 | SEC filing · Form 6-K | -2.93% | -4.56% | |
| Form F-3 Galmed Pharmaceuticals | SEC filing · Form F-3 | -2.93% | -4.56% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | +0.78% | -5.43% | |
| Form 6-K Galmed Pharmaceuticals For: Oct 21 | SEC filing · Form 6-K | -2.89% | +2.78% | |
| Form F-1 Galmed Pharmaceuticals | SEC filing · Form F-1 | -2.89% | +2.78% | |
| Form 6-K Galmed Pharmaceuticals For: Oct 15 | SEC filing · Form 6-K | +3.42% | -5.21% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 25 | SEC filing · Form 6-K | -1.79% | -15.29% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 20 | SEC filing · Form 6-K | +6.23% | -4.49% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 19 | SEC filing · Form 6-K | -6.05% | -7.69% | |
| Form 6-K Galmed Pharmaceuticals For: Sep 16 | SEC filing · Form 6-K | +11.85% | +179.63% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | +0.00% | +3.49% | |
| Form 6-K Galmed Pharmaceuticals For: Aug 30 | SEC filing · Form 6-K | +2.90% | +0.97% | |
| Form F-1 Galmed Pharmaceuticals | SEC filing · Form F-1 | +2.90% | +0.97% | |
| Form 6-K Galmed Pharmaceuticals For: Jun 30 | SEC filing · Form 6-K | -2.16% | -1.68% | |
| Form 6-K Galmed Pharmaceuticals For: Aug 27 | SEC filing · Form 6-K | -1.00% | -7.52% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 18 | SEC filing · Form 6-K | +0.00% | -1.84% | |
| Form 6-K Galmed Pharmaceuticals For: Jul 11 | SEC filing · Form 6-K | +0.00% | -6.19% | |
| Form 6-K Galmed Pharmaceuticals For: Jun 05 | SEC filing · Form 6-K | +0.00% | +0.86% | |
| Form 6-K Galmed Pharmaceuticals For: May 30 | SEC filing · Form 6-K | +0.53% | -2.60% | |
| Form 20-F Galmed Pharmaceuticals For: Dec 31 | SEC filing · Form 20-F | +0.00% | +5.33% | |
| Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023 | Press release | +0.00% | +5.33% | |
| Form 6-K Galmed Pharmaceuticals For: Mar 19 | SEC filing · Form 6-K | +1.46% | -3.30% | |
| Form 6-K Galmed Pharmaceuticals For: Mar 15 | SEC filing · Form 6-K | -11.24% | -25.59% | |
| Form EFFECT Galmed Pharmaceuticals | SEC filing · Form EFFECT | -1.60% | -0.20% | |
| Form 6-K Galmed Pharmaceuticals For: Nov 22 | SEC filing · Form 6-K | -4.88% | -0.97% | |
| Form POS AM Galmed Pharmaceuticals | SEC filing · Form POS | -4.88% | -0.97% | |
| Form 6-K Galmed Pharmaceuticals For: Nov 20 | SEC filing · Form 6-K | +0.03% | +5.91% | |
| Form POS AM Galmed Pharmaceuticals | SEC filing · Form POS | +0.00% | -1.23% |
Keep exploring
More GLMD: earnings → · analyst actions → · GLMD overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) | 159 | -1.17% | 27% |
| DURECT Corporation (DRRX) | 159 | +0.03% | 51% |
| GT Biopharma, Inc. (GTBP) | 159 | -0.91% | 32% |
| ImmuCell Corporation (ICCC) | 159 | 0.00% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.